172 related articles for article (PubMed ID: 28181108)
1. Circulating levels of fibroblast growth factor 21 in early-stage diabetic kidney disease.
Esteghamati A; Khandan A; Momeni A; Behdadnia A; Ghajar A; Nikdad MS; Noshad S; Nakhjavani M; Afarideh M
Ir J Med Sci; 2017 Aug; 186(3):785-794. PubMed ID: 28181108
[TBL] [Abstract][Full Text] [Related]
2. Circulating Fibroblast Growth Factors 21 and 23 as Biomarkers of Progression in Diabetic Nephropathy in Type 2 Diabetes with Normoalbuminuria.
El-Saeed AM; El-Mohasseb GF
Egypt J Immunol; 2017 Jun; 24(2):93-99. PubMed ID: 29528583
[TBL] [Abstract][Full Text] [Related]
3. Serum fibroblast growth factor 21 concentrations in type 2 diabetic retinopathy patients.
Esteghamati A; Momeni A; Abdollahi A; Khandan A; Afarideh M; Noshad S; Nakhjavani M
Ann Endocrinol (Paris); 2016 Oct; 77(5):586-592. PubMed ID: 27106505
[TBL] [Abstract][Full Text] [Related]
4. Circulating fibroblast growth factor 21 levels predict progressive kidney disease in subjects with type 2 diabetes and normoalbuminuria.
Lee CH; Hui EY; Woo YC; Yeung CY; Chow WS; Yuen MM; Fong CH; Xu A; Lam KS
J Clin Endocrinol Metab; 2015 Apr; 100(4):1368-75. PubMed ID: 25625802
[TBL] [Abstract][Full Text] [Related]
5. Assessment of fibroblast growth factor 21 in children with type 1 diabetes mellitus in relation to microvascular complications.
Tantawy N; Sherif E; Matter RM; Salah N; Abozeid NE; Atif H
Pediatr Endocrinol Diabetes Metab; 2023; 29(2):64-74. PubMed ID: 37728457
[TBL] [Abstract][Full Text] [Related]
6. Association of serum fibroblast growth factor 21 with diabetic complications and insulin dose in patients with type 1 diabetes mellitus.
Taniguchi H; Nirengi S; Ishihara K; Sakane N
PLoS One; 2022; 17(2):e0263774. PubMed ID: 35192641
[TBL] [Abstract][Full Text] [Related]
7. Circulating Levels of Soluble Klotho and Fibroblast Growth Factor 23 in Diabetic Patients and Its Association with Early Nephropathy.
Farías-Basulto A; Martínez-Ramírez HR; Gómez-García EF; Cueto-Manzano AM; Cortés-Sanabria L; Hernández-Ramos LE; Ramírez-López G; Mendoza-Carrera F
Arch Med Res; 2018 Oct; 49(7):451-455. PubMed ID: 30718148
[TBL] [Abstract][Full Text] [Related]
8. The U-shaped relationship between fibroblast growth factor 21 and microvascular complication in type 2 diabetes mellitus.
Jung CH; Jung SH; Kim BY; Kim CH; Kang SK; Mok JO
J Diabetes Complications; 2017 Jan; 31(1):134-140. PubMed ID: 27839924
[TBL] [Abstract][Full Text] [Related]
9. Fibroblast Growth Factor 21 Attenuates Diabetes-Induced Renal Fibrosis by Negatively Regulating TGF-β-p53-Smad2/3-Mediated Epithelial-to-Mesenchymal Transition via Activation of AKT.
Lin S; Yu L; Ni Y; He L; Weng X; Lu X; Zhang C
Diabetes Metab J; 2020 Feb; 44(1):158-172. PubMed ID: 31701691
[TBL] [Abstract][Full Text] [Related]
10. Association between serum fibroblast growth factor 21 and diabetic nephropathy.
Jian WX; Peng WH; Jin J; Chen XR; Fang WJ; Wang WX; Qin L; Dong Y; Su Q
Metabolism; 2012 Jun; 61(6):853-9. PubMed ID: 22136913
[TBL] [Abstract][Full Text] [Related]
11. Fibroblast Growth Factor 21 is Related to Atherosclerosis Independent of Nonalcoholic Fatty Liver Disease and Predicts Atherosclerotic Cardiovascular Events.
Wu L; Qian L; Zhang L; Zhang J; Zhou J; Li Y; Hou X; Fang Q; Li H; Jia W
J Am Heart Assoc; 2020 Jun; 9(11):e015226. PubMed ID: 32431189
[TBL] [Abstract][Full Text] [Related]
12. Circulating FGF21 Concentration, Fasting Plasma Glucose, and the Risk of Type 2 Diabetes: Results From the PREVEND Study.
Post A; Dam WA; Sokooti S; Groothof D; Gloerich J; van Gool AJ; Kremer D; Gansevoort RT; van den Born J; Kema IP; Franssen CFM; Dullaart RPF; Bakker SJL
J Clin Endocrinol Metab; 2023 May; 108(6):1387-1393. PubMed ID: 36533509
[TBL] [Abstract][Full Text] [Related]
13. Fibroblast growth factor 21 in chronic kidney disease.
Suassuna PGA; de Paula RB; Sanders-Pinheiro H; Moe OW; Hu MC
J Nephrol; 2019 Jun; 32(3):365-377. PubMed ID: 30430412
[TBL] [Abstract][Full Text] [Related]
14. Relationship of fibroblast growth factor 21 with baseline and new on-study microvascular disease in the Fenofibrate Intervention and Event Lowering in Diabetes study.
Ong KL; Januszewski AS; O'Connell R; Buizen L; Jenkins AJ; Xu A; Sullivan DR; Barter PJ; Scott RS; Taskinen MR; Rye KA; Keech AC;
Diabetologia; 2015 Sep; 58(9):2035-44. PubMed ID: 26055067
[TBL] [Abstract][Full Text] [Related]
15. The serum fibroblast growth factor 21 is correlated with retinopathy in patients with type 2 diabetes mellitus.
Heidari Z; Hasanpour M
Diabetes Metab Syndr; 2021; 15(6):102296. PubMed ID: 34592531
[TBL] [Abstract][Full Text] [Related]
16. Increased circulating FGF21 level predicts the burden of metabolic demands and risk of vascular diseases in adults with type 2 diabetes.
Liu Z; Peng Y; Li S; Lin Y; Huang Y; Chen W; Bao C; Zhou Z; Lin Z; Chen L
BMC Endocr Disord; 2023 Dec; 23(1):272. PubMed ID: 38057786
[TBL] [Abstract][Full Text] [Related]
17. Distinct changes in serum fibroblast growth factor 21 levels in different subtypes of diabetes.
Xiao Y; Xu A; Law LS; Chen C; Li H; Li X; Yang L; Liu S; Zhou Z; Lam KS
J Clin Endocrinol Metab; 2012 Jan; 97(1):E54-8. PubMed ID: 22013098
[TBL] [Abstract][Full Text] [Related]
18. Serum fibroblast growth factor 21 levels is associated with lower extremity atherosclerotic disease in Chinese female diabetic patients.
Zhang X; Hu Y; Zeng H; Li L; Zhao J; Zhao J; Liu F; Bao Y; Jia W
Cardiovasc Diabetol; 2015 Mar; 14():32. PubMed ID: 25850006
[TBL] [Abstract][Full Text] [Related]
19. Serum fibroblast growth factor 21 levels are related to subclinical atherosclerosis in patients with type 2 diabetes.
Xiao Y; Liu L; Xu A; Zhou P; Long Z; Tu Y; Chen X; Tang W; Huang G; Zhou Z
Cardiovasc Diabetol; 2015 Jun; 14():72. PubMed ID: 26047614
[TBL] [Abstract][Full Text] [Related]
20. The relationship between serum levels of fibroblast growth factor 21 and diabetic retinopathy.
Mousavi Z; Bonakdaran S; Sahebkar A; Yaghoubi G; Yaghoubi MA; Davoudian N; Mohebbi M
EXCLI J; 2017; 16():1249-1256. PubMed ID: 29285020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
